» Articles » PMID: 31952261

Contribution of Dendritic Cells in Protective Immunity Against Respiratory Syncytial Virus Infection

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2020 Jan 19
PMID 31952261
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Respiratory syncytial virus (RSV) is a major cause of severe respiratory disease in infants and the elderly. The socioeconomic burden of RSV infection is substantial because it leads to serious respiratory problems, subsequent hospitalization, and mortality. Despite its clinical significance, a safe and effective vaccine is not yet available to prevent RSV infection. Upon RSV infection, lung dendritic cells (DCs) detecting pathogens migrate to the lymph nodes and activate the adaptive immune response. Therefore, RSV has evolved various immunomodulatory strategies to inhibit DC function. Due to the capacity of RSV to modulate defense mechanisms in hosts, RSV infection results in inappropriate activation of immune responses resulting in immunopathology and frequent reinfection throughout life. This review discusses how DCs recognize invading RSV and induce adaptive immune responses, as well as the regulatory mechanisms mediated by RSV to disrupt DC functions and ultimately avoid host defenses.

Citing Articles

Multiomics as instrument to promote 3P medical approaches for the overall management of respiratory syncytial viral infections.

Bajinka O, Ouedraogo S, Li N, Zhan X EPMA J. 2025; 16(1):217-238.

PMID: 39991100 PMC: 11842696. DOI: 10.1007/s13167-024-00395-z.


Immune Responses to Respiratory Syncytial Virus Vaccines: Advances and Challenges.

Silva G, Borges S, Pozzebon B, Souza A Microorganisms. 2024; 12(11).

PMID: 39597694 PMC: 11596275. DOI: 10.3390/microorganisms12112305.


The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response.

Rivas-Fuentes S, Salgado-Aguayo A, Santos-Mendoza T, Sevilla-Reyes E Int J Mol Sci. 2024; 25(18).

PMID: 39337288 PMC: 11432029. DOI: 10.3390/ijms25189800.


The role of respiratory syncytial virus G protein in immune cell infection and pathogenesis.

Anderson J, Do L, van Kasteren P, Licciardi P EBioMedicine. 2024; 107:105318.

PMID: 39217853 PMC: 11402919. DOI: 10.1016/j.ebiom.2024.105318.


Inhibiting retinoic acid signaling in dendritic cells suppresses respiratory syncytial virus infection through enhanced antiviral immunity.

Farazuddin M, Acker G, Zourob J, OKonek J, Wong P, Morris S iScience. 2024; 27(7):110103.

PMID: 39045100 PMC: 11263793. DOI: 10.1016/j.isci.2024.110103.


References
1.
Crank M, Ruckwardt T, Chen M, Morabito K, Phung E, Costner P . A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019; 365(6452):505-509. DOI: 10.1126/science.aav9033. View

2.
Chirkova T, Lin S, Oomens A, Gaston K, Boyoglu-Barnum S, Meng J . CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. J Gen Virol. 2015; 96(9):2543-2556. PMC: 4635495. DOI: 10.1099/vir.0.000218. View

3.
Jafri H, Wu X, Makari D, Henrickson K . Distribution of respiratory syncytial virus subtypes A and B among infants presenting to the emergency department with lower respiratory tract infection or apnea. Pediatr Infect Dis J. 2013; 32(4):335-40. DOI: 10.1097/INF.0b013e318282603a. View

4.
Spann K, Tran K, Chi B, Rabin R, Collins P . Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol. 2004; 78(8):4363-9. PMC: 374276. DOI: 10.1128/jvi.78.8.4363-4369.2004. View

5.
Ghildyal R, Mills J, Murray M, Vardaxis N, Meanger J . Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol. 2002; 83(Pt 4):753-757. DOI: 10.1099/0022-1317-83-4-753. View